Dernières actualités
-
Philips and B. Braun launch Onvision needle tip tracking, a breakthrough in real-time ultrasound guidance for regional anesthesia
Available on the latest version of the B. Braun and Philips Xperius ultrasound system, Onvision gives anesthesiologists the confidence to accurately position the needle tip inside the body.
-
B. Braun Successfully Integrates with Guard RFID Solutions Inc.
This interoperability is designed to improve workflow and optimize pump utilization while improving care.
-
B. Braun Announces $1 Billion Investment to Alleviate IV Fluid Shortages in the U.S. Healthcare System
Solutions for Life represents B. Braun’s commitment to expand capacity and help ensure supply of life-saving fluids for hospitals, outpatient settings, and other care institutions.
-
Innovative solutions and exiting entrepreneurs: B. Braun Accelerator Demo Day
Melsungen. Innovative ideas can come from all sorts of directions – you just have to confront them with courage and openness. This was impressively underscored by “Demo Day” on Thursday, August 30th when the results of the first round of the B. Braun Accelerators were presented.
-
B. Braun inaugurates Europe’s most modern production site in Saxony
Wilsdruff/Melsungen. On September 4th, B. Braun Melsungen AG opened up Europe’s most modern production site for dialyzers with a celebratory inauguration event in Wilsdruff. Dialyzers are filter units for the dialysis of people with chronic kidney failure. With this investment, B. Braun hopes to double its production capacity in Saxony.
-
Drug-coated Balloon SeQuent® Please Shows Positive Results in Largest Randomized Clinical Trial
Munich, August 28th: Prof. Raban Jeger from the University Hospital Basel (Switzerland) reported the late breaking results from the BASKET-SMALL 2 trial at the ESC congress in Munich, Germany.
-
2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros
B. Braun Melsungen AG finished the fiscal year 2017 with total sales of € 6,789 million (previous year: € 6,471 million).
-
werk_39 wins design award
The innovation laboratory "werk_39," together with the chilli mind design agency was recognized with the "iF gold award" at this year's iF DESIGN AWARD in the category of Service Design. An international, independent and top-class jury of experts attested to the exceptional design achievements of the werk_39 team for its premises at the location on Rote Straße in Tuttlingen.
-
Second design award for 3D camera heads from Aesculap
For the second time prestigious design award for Aesculap: The subsidiary company of the B. Braun Group won the internationally coveted German Design Award for their innovative 3D camera heads used in endoscopic laparoscopy. Aesculap already received the renowned Red Dot Award for this last year.
-
Four start-ups chosen for the B. Braun Accelerator Program
In order to promote innovative company foundations in the medical technology industry and make them available to the Group, the B. Braun Melsungen AG launched the B. Braun Accelerator Program in November 2017. Now the first four start-ups were selected to participate in the program.
-
Aesculap and Christoph Miethke found joint venture
Aesculap AG, a subsidiary of B. Braun Melsungen AG, together with Christoph Miethke announced the formation of the joint venture B. Braun Miethke GmbH & Co. KG.
-
B. Braun is Digital Transformer of the Year
B. Braun has won the “Digital Transformer of the Year” award, which was presented for the first time ever, in the category “Life Sciences.” An expert jury selected the best companies from suggestions of 1,100 representatives from industry, customer bases and the media.
-
B. Braun is extending its product portfolio in the area of acidic concentrate preparation for dialysis therapy
B. Braun Avitum AG is cooperating with INTERMEDT Medizin & Technik GmbH in Ostrhauderfehn, Germany, to improve the treatment of dialysis patients with innovative products.
-
New Research Published in the Journal of the Association for Vascular Access
Study Published in the Journal of the Association for Vascular Access Offers Evidence to Support the Use of B. Braun Medical’s Peripheral IV Checklist.
-
B. Braun Focused on Peripheral Vascular Access & Hazardous Drug Safety at INS
B. Braun Medical Inc. will sponsor three educational programs at the Infusion Nurses Society (INS) Spring 2017 Conference.
-
B. Braun Advocates for Safer Handling of Hazardous Drugs
B. Braun Medical Inc. will debut ReadyFor800.com at The Oncology Nursing Society’s Annual Conference.
-
Change in the B. Braun Management Board and the Aesculap Management Board
Melsungen. Prof. Dr. Hanns-Peter Knaebel has resigned as a Member of the Management Board of B. Braun Melsungen AG and as Chairman of the Management Board of Aesculap AG for personal reasons effective April 11, 2017.
-
B. Braun Launches Easypump® Home Infusion Therapy App For Healthcare Professionals and Patients
Clinicians and patients using B. Braun Medical Inc.’s Easypump® ST/LT Elastomeric Infusion Pump System have a new tool to help them safely administer medication. B. Braun is introducing an innovative app that offers educational content to clinicians and patients on the safe use and features of the Easypump for short- and long-term home infusion therapy.
-
B. Braun and Philips join forces to innovate in ultrasound-guided regional anesthesia and vascular access
Strategic alliance combines B. Braun’s leadership in regional anesthesia and Philips’ leadership in image guided therapy solutions with the aim to make regional anesthesia and vascular access easier to perform, leading to enhanced patient care and hospital efficiency. Xperius* is the new mobile ultrasound system specifically designed as the platform to support current and future integrated solutions in ultrasound-guided regional anesthesia.
-
B. Braun continues its sales and earnings growth
B. Braun Melsungen AG has successfully completed the 2016 financial year.